Challenges and Prospects of Travel Medicine in Nigeria

Mar 10, 2026, 2:41 AM

Hover over text to view sources

Travel medicine in Nigeria is an emerging field, reflecting the growing number of Nigerians traveling abroad as well as the influx of international visitors. However, the landscape is fraught with challenges that impede effective practice. A recent cross-sectional survey aimed to investigate the experiences and knowledge of travel medicine practitioners in Nigeria, shedding light on the critical issues facing this important area of healthcare.

The survey received responses from 387 healthcare practitioners, yielding a response rate of approximately 9.67% from the 3,990 emails dispatched. The median professional experience among respondents was 25 years, indicating a wealth of knowledge within the surveyed group.

A significant finding from the survey was the general lack of awareness regarding travel-related health risks. Despite the rising incidence of diseases such as malaria and typhoid among travelers, many practitioners reported insufficient knowledge to manage these cases effectively. For instance, 57.6% of respondents rated their knowledge of malaria as low, emphasizing a pressing need for enhanced training and resources in travel medicine.

Moreover, the survey revealed that while 32.8% of practitioners had encountered suspected or confirmed cases of malaria, the majority still struggled with effective management protocols. This highlights the necessity for improved educational initiatives tailored to travel medicine, specifically focusing on the epidemiology of diseases prevalent in travel settings and preventative measures such as vaccinations and chemoprophylaxis for malaria.

The challenges are exacerbated by the broader context of healthcare in Nigeria, which is often characterized by unreliable medical facilities and a shortage of essential medications. The US Department of State has issued travel advisories indicating that healthcare services do not meet US or European standards. Many hospitals require immediate cash payments and often lack basic emergency services, which can deter travelers from seeking necessary medical attention while abroad.

Security concerns are another significant barrier to effective travel medicine practice in Nigeria. The country faces risks from crime, terrorism, and civil unrest, which can complicate the provision of healthcare services. High-risk areas, including the northeast and various southern regions, present additional challenges for practitioners who must navigate both health and safety issues when advising travelers.

To address these multifaceted challenges, the survey's findings suggest a need for the establishment of dedicated travel medicine services within the Nigerian healthcare system. Such services could provide comprehensive pre-travel consultations, including risk assessments and recommendations for vaccinations and prophylaxis. Enhanced training for primary care physicians (PCPs) on travel health issues, as seen in other contexts like Oman, could also improve the quality of care provided to travelers.

Additionally, there is an urgent need for developing a structured framework that encourages collaboration between healthcare providers and public health authorities. This could facilitate better data collection on travel-related diseases, help identify high-risk areas, and ultimately lead to more effective public health interventions.

In conclusion, while the prospects for travel medicine in Nigeria are promising, they are contingent upon addressing the significant challenges faced by practitioners. By focusing on education, resource allocation, and the establishment of dedicated travel medicine services, Nigeria can enhance its capacity to manage the health needs of travelers and mitigate the risks associated with travel-related diseases. The insights from the recent survey underscore the critical need for ongoing research and innovation in this vital healthcare sector.

FDA Grants Breakthrough Therapy Status to Innovative CAR-T Cell Therapy

The US FDA has granted Breakthrough Therapy designation to Wugen's CAR-T cell therapy, WU-CART-007, aimed at treating aggressive T-cell cancers. Developed at Washington University, this therapy shows promising early results in clinical trials, offering hope to patients with limited treatment options.

Revolutionary CAR-T Cell Therapy Receives FDA Breakthrough Designation

The FDA has granted Breakthrough Therapy designation to an innovative CAR-T cell therapy developed by researchers at WashU Medicine, targeting aggressive T-cell cancers. This designation aims to expedite the approval process for treatments showing significant promise in clinical trials.

FDA Grants Breakthrough Therapy Designation to Innovative CAR-T Therapy

The FDA has awarded Breakthrough Therapy designation to a novel CAR-T cell therapy developed by WashU Medicine, aimed at treating aggressive T-cell cancers. This designation accelerates the therapy's regulatory review, potentially improving outcomes for patients who have limited treatment options.

AI Tool Offers New Hope for Diagnosing Advanced Heart Failure

A recent study reveals that an AI-powered method using cardiac ultrasound data can significantly enhance the diagnosis of advanced heart failure. This approach aims to address the diagnostic bottleneck, potentially improving care for thousands of patients annually.

Innovative Vaccine Offers Broad Protection Against Respiratory Infections

A groundbreaking vaccine, currently tested in mice, shows promise in providing extensive protection against various respiratory infections and allergens. By enhancing both innate and adaptive immune responses, this vaccine could transform how seasonal vaccinations are approached in the future.